Trials / Conditions / Allogeneic Stem Cell Transplant

Allogeneic Stem Cell Transplant

11 registered clinical trials studyying Allogeneic Stem Cell Transplant — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Phase II Study of Resistant Potato Starch Plus Deferasirox to Improve Outcomes in Patients Undergoing Allogene NCT06784336	University of Michigan Rogel Cancer Center	Phase 2
Active Not Recruiting	Psychosocial Mobile App for Chronic Graft-Versus-Host Disease NCT05690971	Massachusetts General Hospital	N/A
Completed	Early Chimerism Following Allogeneic Stem-Cell Transplant NCT03689907	Dartmouth-Hitchcock Medical Center	—
Completed	Donor-Derived Viral Specific T-cells (VSTs) for Prophylaxis Against Viral Infections After Allogeneic Stem Cel NCT03883906	Children's Hospital Medical Center, Cincinnati	Phase 2
Completed	Pharmacokinetics of Posaconazole (Noxafil®) as Prophylaxis for Invasive Fungal Infections NCT02805946	Radboud University Medical Center	Phase 4
Completed	Nutrition and Outcomes of Hematopoietic Cell Transplantation (HCT) NCT03419078	Imperial College Healthcare NHS Trust	—
Completed	Pharmacokinetics of Micafungin Given Twice Weekly Intravenously Compared to Micafungin Given Daily to Patients NCT02172768	Radboud University Medical Center	Phase 2
Recruiting	Donor-Derived Viral Specific T-cells (VSTs) NCT02048332	Children's Hospital Medical Center, Cincinnati	Phase 1 / Phase 2
Completed	Assessment of MicroRNA Expression in Acute Graft-versus-Host Disease NCT01521039	Ohio State University Comprehensive Cancer Center	—
Withdrawn	CD56+CD3- NK Cells Following Allogeneic Stem Cell Transplantation NCT01336478	Imperial College London	Phase 1
Completed	Trial of Allogeneic Stem Cell Transplants From HLA Compatible, Related and Unrelated Donors After a Myeloablat NCT00587054	Memorial Sloan Kettering Cancer Center	Phase 2